- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03419546
Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
October 17, 2018 updated by: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Clinical Validation Trial of the Single-use Bronchoscope Ambu® aScope ™ 4
The aim of this study is to evaluate the usefulness of the new Ambu® aScope ™ 4 bronchoscope, in the usual practice of low complexity diagnostic bronchoscopy managed by bronchoscopists who meet the minimum training requirements (having performed 100 supervised procedures [ 10]) and maintenance of competition (with more than 25 bronchoscopies per year [10]).
Study Overview
Status
Completed
Conditions
Detailed Description
Muticentric trial to evaluate three outcomes
- Describe the experience of bronchoscopists performing low complexity bronchoscopic procedures with the Ambu® aScope ™ 4.
- Collect the opinion of bronchoscopists about the technical characteristics of the device subject to study through a standardized questionnaire.
- Analyze the quality of both microbiological and cytological samples obtained through the disposable bronchoscope.
Study Type
Observational
Enrollment (Actual)
216
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28040
- Fundacion Jimenez Diaz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
- Patients that require a low complexity bronchoscopy that accept the informed consent
Description
Inclusion Criteria:
- Low complexity bronchoscopies in patients that need to undergo a low complexity bronchoscopy in the sites of the study
Exclusion Criteria:
- No acceptance of the informed consent
- Any procedure out of a low complexity bronchoscopy in the sites of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Bronchoscopic procedures
Bronchoscopies performed in different sites to evaluate the level of satisfaction of the operators with the device Ambu® aScope™ 4
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bronchoscope Quality questionnaire evaluation
Time Frame: Feb 2018- july 2018
|
- A numeric scale describes the experience of bronchoscopists performing low complexity bronchoscopic procedures with the Ambu® aScope ™ 4.
|
Feb 2018- july 2018
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
-Opinion of the operator -Quality of the sample
Time Frame: Feb 2018 -july 2018
|
1.A numeric scale collects the opinion of bronchoscopists about the technical characteristics of the device subject to study through a standardized questionnaire.
|
Feb 2018 -july 2018
|
- Sample quality
Time Frame: Feb 2018- july 2018
|
2.Analyze the quality of both microbiological and cytological samples obtained through the disposable bronchoscope describing the diagnostic yield.
|
Feb 2018- july 2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Javier Flandes, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2018
Primary Completion (ACTUAL)
August 31, 2018
Study Completion (ACTUAL)
August 31, 2018
Study Registration Dates
First Submitted
January 19, 2018
First Submitted That Met QC Criteria
January 26, 2018
First Posted (ACTUAL)
February 5, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 18, 2018
Last Update Submitted That Met QC Criteria
October 17, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- EO 131/2017_FJD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchoscopy
-
Paion UK Ltd.Premier Research Group plcCompleted
-
Guangzhou Institute of Respiratory DiseaseCompleted
-
MaineHealthCompleted
-
Pulmonx CorporationCompleted
-
Chang Gung Memorial HospitalCompleted
-
Pusan National University HospitalUnknownBronchoscopyKorea, Republic of
-
University of OklahomaCompletedBronchoscopyUnited States
-
University Hospital, GenevaCentre Valaisan de Pneumologie, CH-3960MontanaCompleted
-
Eisai Inc.PPD; Covance; Quest Pharmaceutical ServicesTerminated
-
Lena NilssonCompletedSedation, Bronchoscopy